A positive view on a negative trial with DOAC after TAVR
This video was recorded at the Congress of the American College of Cardiology (ACC) 2022.
Megan Coylewright is interventional cardiologist at the Erlanger Health System in Chattanooga, TN, VS.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: